Safety Assessment of Dose-Escalated 225Ac-PSMA-617 Radioligand Therapy in Patients with Advanced Metastatic Castration-Resistant Prostate Cancer Following Standard Treatment Failure. (2025). Voprosy Onkologii, 71(5), OF-2520. https://doi.org/10.37469/0507-3758-2025-71-5-OF-2520